Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-04-25
1999-02-02
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546115, 546116, 546114, 546118, 546 84, 546 86, 546 87, 546 80, 546 89, 546 92, 546122, 546123, 546113, 546 88, 514301, 514303, 514300, 514292, 514291, A61K 31435, C07D49504, C07D49104
Patent
active
058665870
ABSTRACT:
Compound of formula (I): ##STR1## in which: m, n, which are identical or different, represent 0, 1 or 2,
REFERENCES:
patent: 4193997 (1980-03-01), Boigegrain et al.
patent: 5672615 (1997-09-01), MacPherson et al.
A.L. Harris, The Lancet, vol. 349, SH 13-15, May, 1997.
M. Skobe, Nature Medicine, vol. 3, No. 11, 1222-1227, Nov. 1997.
J. Nemunaitis, Clinical Cancer Research, vol. 4, 1101-1109, May 1998.
Nagase, H., "Matrix metalloproteinases," in Zinc Metalloproteases in Health and Disease, pp. 177-181, 1996.
Atassi Ghanem
Bonnet Jacqueline
De Nanteuil Guillaume
Paladino Joseph
Pierre Alain
Adir et Compagnie
Kessinger Ann M.
Shah Mukund J.
LandOfFree
Metalloprotease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metalloprotease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metalloprotease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1117781